期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
The Diagnostic Value of Oligoclonal Band Detection in Viral Encephalitis
1
作者 Anqi Huang Xianyue Meng Xueli Li# 《Journal of Behavioral and Brain Science》 2024年第1期23-31,共9页
Objective: This study aims to explore the differences in cerebrospinal fluid oligoclonal band (CSF-OCB) expression among different age groups in viral encephalitis and its reference value for diagnosis. Methods: Forty... Objective: This study aims to explore the differences in cerebrospinal fluid oligoclonal band (CSF-OCB) expression among different age groups in viral encephalitis and its reference value for diagnosis. Methods: Forty-two patients with viral encephalitis were divided into two groups: 25 adults and 17 children. The presence of oligoclonal bands in the cerebrospinal fluid (CSF) was detected using polyacrylamide gel electrophoresis, and CSF routine analysis was conducted for comparative analysis. Results: The CSF-OCB positivity rate was higher in the adult group (48%) compared with the pediatric group (11.76%), with a statistically significant difference (P Conclusion: 1) The expression of CSF-OCB positivity in patients with viral encephalitis is age-related, with higher positivity rates observed in adults compared to children. 2) Although CSF oligoclonal band detection is not a specific diagnostic marker for viral encephalitis in adults, it still holds certain reference value. 展开更多
关键词 oligoclonal Band Detection Viral Encephalitis Routine Analysis of Cerebrospinal Fluid Age
下载PDF
Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders 被引量:5
2
作者 Hai Chen Shi-Meng Liu +4 位作者 Xu-Xiang Zhang Ya-Ou Liu Si-Zhao Li Zheng Liu Hui-Qing Dong 《Chinese Medical Journal》 SCIE CAS CSCD 2016年第17期2079-2084,共6页
Background: Neuromyelitis optica spectrum disorder (NMOSD) was long believed to be an aggressive form of multiple sclerosis (MS). This study aimed to describe the clinical features of patients with MS and NMOSD t... Background: Neuromyelitis optica spectrum disorder (NMOSD) was long believed to be an aggressive form of multiple sclerosis (MS). This study aimed to describe the clinical features of patients with MS and NMOSD to assist in differential diagnoses in clinical practice. Methods: Data including the patients' serum and cerebrospinal fluid (CSF) tests, image findings, and clinical information from 175 patients with MS or NMOSD at Xuanwu Hospital, Capital Medical University from November 2012 to May 2014 were collected and analyzed retrospectively. An enzyme-linked immunosorbent assay was performed to detect the myelin oligodendrocyte glycoprotein (MOG) autoantibodies in CSF and serum. Cell-based assays were used to detect aquaporin-4-antibody (AQP4-Ab). The Chi-square test was used to compare the categorical variables. Wilcoxon rank sum test was peribrmed to analyze the continuous variables. Results: Totally 85 MS patients (49%) and 90 NMOSD patients (51%) were enrolled, including 124 (71%) women and 51 (29%) men. Fewer MS patients (6%) had autoinamune diseases compared to NMOSD (19%) (x2= 6.9, P 〈 0.01 ). Patients with NMOSD had higher Expanded Disability Status Scale scores (3.5 [3]) than MS group (2 [2]) (x2= -3.69, P 〈 0.01). The CSF levels of white cell count and protein in both two groups were slightly elevated titan the normal range, without significant difference between each other. Positivity of serum AQP4-Ab in NMOSD patients was higher than that in MS patients (MS: 0, NMOSD: 67%; x2= 63.9, P 〈 0.01 ). Oligoclonal bands in CSF among NMOSD patients were remarkably lower than that among MS (MS: 59%, NMOSD: 20%; x2= 25.7, P 〈 0.01). No significant difference of MOG autoantibodies was found between the two groups. Conclusion: The different CSF features combined with clinical, magnetic resonance imaging, and serum characteristics between Chinese patients with MS and NMOSD could assist in the differential diagnosis. 展开更多
关键词 AQUAPORIN-4 Cerebrospinal Fluid Demyelinating Disease Multiple Sclerosis Myelin Oligodendrocyte Glycoprotein Neuromyelitis Optica Spectrum Disorder oligoclonal bands
原文传递
CSF biomarkers in multiple sclerosis:beyond neuroinflammation
3
作者 Simona Toscano Francesco Patti 《Neuroimmunology and Neuroinflammation》 2021年第1期14-41,共28页
For many years,quantifiable biomarkers in neurological diseases have represented a hot topic.In multiple sclerosis(MS),cerebrospinal fluid biomarkers have played a diagnostic role since the introduction of Poser's... For many years,quantifiable biomarkers in neurological diseases have represented a hot topic.In multiple sclerosis(MS),cerebrospinal fluid biomarkers have played a diagnostic role since the introduction of Poser's criteria in 1983,with IgG oligoclonal bands playing a supporting role in an epoch prior to magnetic resonance imaging and a complementary one after the introduction of McDonald criteria in 2001.Nowadays,that supporting role has turned into a main one in substituting for dissemination in time and defining the diagnosis of MS in patients with a first clinical event,according to the 2017 revised McDonald criteria.Possibly kappa free light chains,N-CAM,chitinase 3-like protein 1 and IgM oligoclonal bands,not yet implemented in clinical practice,could similarly gain importance in the near future.Furthermore,the increasing knowledge of molecular mechanisms leading to chronic inflammation has enhanced interest in looking for biomarkers of disease activity,better defining the MS phenotype and patients with highly active disease.Accordingly,myelin proteins,intermediate filaments,metalloproteinases and other molecules involved in the inflammatory cascade,are currently under investigation.Finally,it has long been known that axonal loss occurs from the early phases,leading to a progressive neurological deterioration.Since established criteria to assess treatment failure and transition to progressive forms are still lacking,both treatment response and prognostic biomarkers would be useful to predict MS course,and neurofilaments seem to have this potential.The purpose of this review article was to illustrate biomarkers that have been already validated or require further validation after proving to be useful in exploratory studies and potentially could prove useful in clinical practice in the coming years. 展开更多
关键词 Multiple sclerosis biomarkers cerebrospinal fluid NEUROFILAMENTS oligoclonal bands disease activity
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部